공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

인터벤션 영상의학(IVR) 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Interventional Radiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 707341
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


인터벤션 영상의학(IVR) 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Interventional Radiology Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

비용 효율이 높은 솔루션과 입원 단기화, 최소침습 수술 선호 고조 등에 의해 치료가 빨라지고, 시술후 바로 퇴원하는 사례가 증가하고 있습니다. 영상진단 기술이 혁신을 이루고 진단시에 실시간 체내영상을 제공할 수 있게 되어 인터벤션 영상의학(IVR) 시장 성장이 촉진되고 있습니다.

세계의 인터벤션 영상의학(IVR: Interventional Radiology) 시장을 조사했으며, 시장 개요, 제품·시술·용도·지역별 시장 규모 추이와 예측, 시장 성장 촉진요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장 촉진요인
    • 만성질환 이환율과 유병률 상승
    • 인터벤션 영상의학(IVR) 장비의 기술 진보
  • 시장 성장 저해요인
    • 높은 방사능 노출 위험
    • 고액의 설비
  • Five Forces 분석
    • 구매자의 협상력
    • 공급 기업의 협상력
    • 신규 진출기업의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 시장 세분화

  • 제품별
    • MRI 시스템
    • 초음파 영상 시스템
    • CT 스캐너
    • 혈관조영 시스템
    • 형광 투시 시스템
    • 생검 장비
    • 기타
  • 시술별
    • 혈관 성형술
    • 혈관 조영술
    • 생검 및 배액
    • 색전술
    • 혈전 용해
    • 척추 성형술
    • 신루 조설술
    • 기타
  • 용도별
    • 순환기
    • 비뇨기
    • 종양
    • 위장
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • Carestream Health
    • Esaote S.P.A.
    • GE Healthcare
    • Hitachi Medical Corporation
    • Hologic Inc.
    • Koninklijke Philips N.V.
    • Shimadzu
    • Siemens AG
    • Toshiba Medical Systems Corporation
    • Samsung Medison

제7장 시장 기회 및 향후 동향

LSH 19.09.20

The global interventional radiology market is projected to register a CAGR of 5.6% over the forecast period, with a revenue of USD 23,822 million in 2020 and expected to reach USD 33,064 million by 2026.

The COVID-19 outbreak showed the impact on the interventional radiology market, as hospital and healthcare services were significantly reduced due to social distancing measures taken by governments across the world. Moreover, the COVID-19 pandemic affected the global economy and showed a huge impact on the functioning of general hospital care for non-COVID-19 patients in hospitals, globally.

In August 2020, a research was published in the SAGE Public Health Emergency Collection. where the researchers studied the overall impact of the COVID-19 pandemic on interventional radiology services in Canada. The study found out that there was a 49.3% overall decrease in demand for acute interventional radiology services across Canada. About 88% of respondents in the study also reported an overall decrease in elective interventional radiology services during the pandemic. A similar scanrio can be observed in other countries tackling COVID-19 related issues in 2020, which impact this market.

The driving factors of the market are rising trend of minimally-invasive procedures, owing to the cost-effective solution and lesser hospital stay. With the help of minimally invasive techniques, patients are treated quickly and are usually discharged from the hospital on the same day. Most of these processeses require imaging technology.

Innovation in imaging technologies, which provides real-time images to the surgeons to show a comprehensive view of internal organs, while diagnosing, is driving the interventional radiology market. One major field of advancement is in augmented reality and artificial intelligence. In contrast to virtual reality, where the field of vision for doctors includes no real images, augmented reality offers the ability to move objects (scopes and devices) inside the body and interact with its surroundings. This dynamic development has a variety of applications for image-led interventions. Artificial intelligence uses complex algorithms to detect abnormalities and anomalies in medical images, like CT scans and X-rays.

Chronic diseases persist, often for illnesses or chronic conditions, such as heart disease, asthma, cancer, and diabetes. Heart disease is the leading cause of death, worldwide. Cardiovascular diseases are the major causes of death, globally. Until years ago, treatment for heart disease meant opening a patient's chest to enter directly into the heart, with surgery, which was very expensive and often exposed the patient to a high risk of infection.

According to GLOBOCAN 2020 figures, in 2019, there were 19,292,729 new cancer cases diagnosed, worldwide. The figures from GLOBOCAN 2020 pointed out that the incidence of new cancer cases in very high HDI (Human Development Index) countries was 8.9 million, followed by 7.4 million in high HDI countries. Medium and low HDI countries had 2.3 million and 0.7 million cases, respectively. The high incidence of cancer cases in countries with higher standards of living is primarily due to the availability and access to better diagnostic procedures. Interventional radiology equipment, like CT scanners and MRI systems, are used extensively for these procedures, due to which their demand is expected to increase

The increasing preference for minimally-invasive procedures and the prevalence of chronic diseases are driving the interventional radiology market. The market is expected to grow steadily, owing to effective interventional procedures performed in lieu of surgery.

Key Market Trends

Application in Cardiology is Expected to Witness the High Growth over the Forecast Period

The pandemic had its effect even on the cardiology segment. In May 2020, an article appearing in the Journal of the American College of Radiology studied the changes in interventional radiology procedures during the COVID-19 pandemic. The study found out that the number of interventional radiology procedures performed during the COVID-19 pandemic decreased from 1,710 to 919 (in a one-month period), constituting a 46% reduction compared to 2019. The study also found out that among CT-guided procedures, there was a 90% reduction in bone and central nervous system-related procedures.

Interventional radiology involves the use of medical imaging to see inside the body coupled with minimally invasive techniques to diagnose and treat cancer, as well as provide relief from symptoms. Surgeons and doctors use tools such as catheters and needles to address a large variety of medical conditions that would have required surgery in the past. The most common diseases treated with this technique include cancers of the lung, liver, kidney, and bone. But this is a growing field, and researchers are exploring its use in treating a variety of other cancer types.

Moreover, the incidence of cardiovascular disorders in recent years has increased. According to the Centers for Disease Control and Prevention, one person in every 36 seconds died in United States due to cardiovascular diseases every year, accounting to 655,000 Americans deaths from heart disease every year.

According to the research article published in the Journal of the American Heart Association, in 2019, 48 institutions in the United States were offering advanced cardiac imaging fellowship training, which includes training on cardiac computed tomography, cardiac magnetic resonance imaging, echocardiography, and nuclear cardiology. This shows the growing importance of cardiac imaging across developed countries.

In December 2020, RSIP Vision launched a new artificial intelligence ultrasound module for rapid and accurate point of care heart evaluations. The company are steadily expected to regain full strength in th market over the forecast period.

Thus, in view of the increasing incidences of cardiovascular diseases and new product launches, the studied market is expected to witness good growth over the forecast period.

North America to Expected to Dominate the Market Over the Forecast Period

The growing burden of chronic diseases, due to changing lifestyles and the growing need for less expensive interventions, leading to the study market, in the United States. Cardiac catheterization is widely used, to diagnose and treat various heart diseases. More than a million cardiac catheterizations and angiographic procedures are performed annually, in the United States.

Several radiology interventions can be used to treat cancer patients. For example, transarterial chemoembolization can interrupt blood supply to a tumor, while radiofrequency ablation (RFA) and microwave ablation can damage cancer cells themselves. According to the National Cancer Institute, in 2018, an estimated 1,735,350 young people with cancer are expected to be diagnosed in the United States, and 609,640 people are likely to die from the disease.

In addition, new product developments and launches are expected to fuel the Canadian market growth over the forecast period. For instance, in May 2020, Guerbet, one of the global companies in medical imaging, announces the registration of Vectorio kit for imaging of hepatocellular carcinoma (HCC), in Canada. Vectorio is a set of Lipiodol resistant medical devices for imaging of liver tumors in adults with known hepatocellular carcinoma during interventional oncology procedures.

The rising prevalence of chronic conditions, such as cancer, diabetes, and others, and the prospects of minimally-invasive, targeted treatments, using imaging guidance, are driving the market in the United States.

Competitive Landscape

The interventional radiology market is highly competitive and consists of global as well as local players, across the world. Some of the companies that currently dominate the market include GE Healthcare, Hitachi Medical Systems, Koninklijke Philips NV, Siemens AG, and Shimadzu Corporation, among others. However, with technological advancements, it is expected that few small and mid-sized companies will also penetrate the market, in the future.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Chronic Diseases
    • 4.2.2 Technological Advancements in Interventional Radiology Devices
  • 4.3 Market Restraints
    • 4.3.1 Risk of High Radiation Exposure
    • 4.3.2 High Cost of Equipment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 MRI Systems
    • 5.1.2 Ultrasound Imaging Systems
    • 5.1.3 CT Scanners
    • 5.1.4 Angiography Systems
    • 5.1.5 Fluoroscopy Systems
    • 5.1.6 Biopsy Devices
    • 5.1.7 Other Products
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Urology & Nephrology
    • 5.2.3 Oncology
    • 5.2.4 Gastroenterology
    • 5.2.5 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States (By Product and By Application)
      • 5.3.1.2 Canada (By Product and By Application)
      • 5.3.1.3 Mexico (By Product and By Application)
    • 5.3.2 Europe
      • 5.3.2.1 Germany (By Product and By Application)
      • 5.3.2.2 United Kingdom (By Product and By Application)
      • 5.3.2.3 France (By Product and By Application)
      • 5.3.2.4 Italy (By Product and By Application)
      • 5.3.2.5 Spain (By Product and By Application)
      • 5.3.2.6 Rest of Europe (By Product and By Application)
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China (By Product and By Application)
      • 5.3.3.2 Japan (By Product and By Application)
      • 5.3.3.3 India (By Product and By Application)
      • 5.3.3.4 Australia (By Product and By Application)
      • 5.3.3.5 South Korea (By Product and By Application)
      • 5.3.3.6 Rest of Asia-Pacific (By Product and By Application)
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 Gulf Cooperation Council (By Product and By Application)
      • 5.3.4.2 South Africa (By Product and By Application)
      • 5.3.4.3 Rest of Middle East & Africa (By Product and By Application)
    • 5.3.5 South America
      • 5.3.5.1 Brazil (By Product and By Application)
      • 5.3.5.2 Argentina (By Product and By Application)
      • 5.3.5.3 Rest of South America (By Product and By Application)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Carestream Health
    • 6.1.2 Esaote SPA
    • 6.1.3 GE Healthcare
    • 6.1.4 Hitachi Medical Corporation
    • 6.1.5 Hologic Inc.
    • 6.1.6 Koninklijke Philips NV
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Siemens Healthineers AG
    • 6.1.9 Canon Medical Systems Corporation
    • 6.1.10 Samsung Medison (Samsung Electronics Co. Ltd)
    • 6.1.11 Medtronic plc
    • 6.1.12 Agfa-Gevert N.V
    • 6.1.13 Teleflex Incorporated
    • 6.1.14 Johnson & Johnson
    • 6.1.15 Cook Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q